Mpox Vaccine Acceptance, Democratic Republic of the Congo

We report general acceptance (61.0%) of an mpox vaccine in the Democratic Republic of the Congo among 5,226 survey respondents. Healthcare workers and respondents in historic mpox-endemic regions had higher acceptance rates. These data highlight the need for increased community engagement and sensi...

Full description

Bibliographic Details
Published in:Emerging Infectious Diseases
Main Authors: Skylar Petrichko, Jason Kindrachuk, Dalau Nkamba, Megan Halbrook, Sydney Merritt, Handdy Kalengi, Leonard Kamba, Michael Beya, Nicole A. Hoff, Christophe Luhata, Didine K. Kaba, Anne W. Rimoin
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2024-12-01
Subjects:
mpox
MPXV
vaccination
viruses
zoonoses
Democratic Republic of the Congo
Online Access:https://wwwnc.cdc.gov/eid/article/30/12/24-1226_article

Internet

https://wwwnc.cdc.gov/eid/article/30/12/24-1226_article

Similar Items